Saturna Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,017
| Closed | -$950K | – | 171 |
|
|
2023
Q4 | $950K | Sell |
4,017
-42
| -1% | -$8.26K | 0.01% | 112 |
|
|
2023
Q3 | $795K | Hold |
4,059
| – | – | 0.01% | 111 |
|
|
2023
Q2 | $853K | Buy |
4,059
+100
| +3% | +$19.9K | 0.01% | 112 |
|
|
2023
Q1 | $799K | Buy |
3,959
+364
| +10% | +$82.5K | 0.02% | 114 |
|
|
2022
Q4 | $783K | Hold |
3,595
| – | – | 0.02% | 110 |
|
|
2022
Q3 | $707K | Hold |
3,595
| – | – | 0.02% | 112 |
|
|
2022
Q2 | $769K | Hold |
3,595
| – | – | 0.02% | 109 |
|
|
2022
Q1 | $1.02M | Hold |
3,595
| – | – | 0.02% | 102 |
|
|
2021
Q4 | $1.35M | Hold |
3,595
| – | – | 0.02% | 99 |
|
|
2021
Q3 | $1.48M | Hold |
3,595
| – | – | 0.03% | 95 |
|
|
2021
Q2 | $1.33M | Hold |
3,595
| – | – | 0.03% | 102 |
|
|
2021
Q1 | $1.04M | Hold |
3,595
| – | – | 0.02% | 103 |
|
|
2020
Q4 | $898K | Hold |
3,595
| – | – | 0.02% | 105 |
|
|
2020
Q3 | $814K | Hold |
3,595
| – | – | 0.02% | 102 |
|
|
2020
Q2 | $627K | Hold |
3,595
| – | – | 0.02% | 116 |
|
|
2020
Q1 | $454K | Buy |
3,595
+1,200
| +50% | +$180K | 0.01% | 121 |
|
|
2019
Q4 | $366K | Hold |
2,395
| – | – | 0.01% | 148 |
|
|
2019
Q3 | $317K | Hold |
2,395
| – | – | 0.01% | 153 |
|
|
2019
Q2 | $340K | Buy |
2,395
+900
| +60% | +$122K | 0.01% | 137 |
|
|
2019
Q1 | $217K | Buy |
+1,495
| New | +$196K | 0.01% | 148 |
|
|
2018
Q4 | – | Sell |
-1,495
| Closed | -$201K | – | 152 |
|
|
2018
Q3 | $201K | Buy |
+1,495
| New | +$185K | 0.01% | 150 |
|
|
2016
Q1 | – | Sell |
-1,495
| Closed | -$120K | – | 198 |
|
|
2015
Q4 | $120K | Hold |
1,495
| – | – | ﹤0.01% | 208 |
|
|
2015
Q3 | $95K | Hold |
1,495
| – | – | ﹤0.01% | 233 |
|
|
2015
Q2 | $105K | Hold |
1,495
| – | – | ﹤0.01% | 238 |
|
|
2015
Q1 | $119K | Hold |
1,495
| – | – | ﹤0.01% | 231 |
|
|
2014
Q4 | $95K | Hold |
1,495
| – | – | ﹤0.01% | 245 |
|
|
2014
Q3 | $89K | Hold |
1,495
| – | – | ﹤0.01% | 299 |
|
|
2014
Q2 | $80K | Hold |
1,495
| – | – | ﹤0.01% | 305 |
|
|
2014
Q1 | $90K | Hold |
1,495
| – | – | ﹤0.01% | 258 |
|
|
2013
Q4 | $79K | Hold |
1,495
| – | – | ﹤0.01% | 265 |
|
|
2013
Q3 | $69K | Hold |
1,495
| – | – | ﹤0.01% | 278 |
|
|
2013
Q2 | $61K | Buy |
+1,495
| New | +$64.1K | ﹤0.01% | 274 |
|
Other funds holding CRL
MG
AI
Saturna Capital's CRL Position: Q1 2024 in Review
Saturna Capital sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 4,017 shares — an estimated $950K sold.
Saturna Capital first reported a position in CRL in Q2 2013 and held it in 32 quarters. The position peaked at $1.48M in Q3 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.
- Saturna Capital reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
- Saturna Capital sold 4,017 Charles River Laboratories shares in Q1 2024, an estimated $950K.
- Saturna Capital first reported a position in Charles River Laboratories in Q2 2013 and held it in 32 quarters.
- Saturna Capital's Charles River Laboratories position peaked at $1.48M in Q3 2021.
- 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.
Based on Saturna Capital's 13F filing for Q1 2024, filed 13 May 2024.